secwatch.observer — SEC 8-K summary
======================================

Issuer:     DANAHER CORP /DE/ (DHR)
CIK:        0000313616
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0000313616-23-000002
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Danaher expects Q4 non-GAAP core revenue growth high-single digits, above prior guidance
--------------------------------------------------------------------------------

- Q4 estimated revenues up low-single-digit% YoY; non-GAAP core revenue growth high-single-digit% vs prior flat to low-single-digit decline guidance.
- Base business core revenue growth high-single-digit%, in line with previous guidance.
- Cepheid respiratory testing revenue exceeded $1B in Q4.
- Full Q4 and FY 2022 earnings call scheduled for Jan 24, 2023 at 8:00 a.m. ET.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313616/000031361623000002/0000313616-23-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313616/000031361623000002/dhr-20230109.htm
  HTML page:      https://secwatch.observer/filing/0000313616-23-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer